MetLife (MET) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

MET Stock Forecast


MetLife (MET) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $95.00, with a high of $101.00 and a low of $84.00. This represents a 38.10% increase from the last price of $68.79.

$65 $73 $81 $89 $97 $105 High: $101 Avg: $95 Low: $84 Last Closed Price: $68.79

MET Stock Rating


MetLife stock's rating consensus is Buy, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 24 Buy (75.00%), 8 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 32 0 8 24 Strong Sell Sell Hold Buy Strong Buy

MET Price Target Upside V Benchmarks


TypeNameUpside
StockMetLife38.10%
SectorFinancial Services Stocks 14.67%
IndustryLife Insurance Stocks 23.69%

Price Target Trends


1M3M12M
# Anlaysts-1016
Avg Price Target-$97.50$96.31
Last Closing Price$68.79$68.79$68.79
Upside/Downside-41.74%40.01%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26386--17
Feb, 26386--17
Jan, 26395--17
Dec, 25485--17
Nov, 25484-117
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 12, 2026Mizuho Securities$100.00$78.8926.76%45.37%
Feb 10, 2026Thomas GallagherEvercore ISI$95.00$77.9221.92%38.10%
Feb 05, 2026UBS$98.00$78.0125.62%42.46%
Jan 14, 2026Mizuho Securities$102.00$77.0832.33%48.28%
Jan 13, 2026Elyse GreenspanWells Fargo$97.00$78.3223.85%41.01%
Jan 08, 2026UBS$94.00$79.7917.81%36.65%
Jan 08, 2026Barclays$90.00$79.4713.25%30.83%
Jan 06, 2026Evercore ISI$97.00$81.7718.63%41.01%
Dec 15, 2025Mizuho Securities$101.00$82.6222.25%46.82%
Dec 15, 2025Morgan Stanley$101.00$83.2221.37%46.82%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Feb 05, 2026UBSBuyBuyhold
Jan 13, 2026Wells FargoOverweightOverweighthold
Dec 15, 2025Morgan StanleyOverweightOverweighthold
Oct 08, 2025BarclaysOverweightOverweighthold
Oct 07, 2025Morgan StanleyOverweightOverweighthold
Sep 15, 2025Wolfe ResearchOutperformOutperforminitialise
Aug 22, 2025Cowen & Co.BuyBuyhold
Jul 14, 2025Morgan StanleyOverweightOverweighthold
Jul 10, 2025Wells FargoOverweightOverweighthold
May 06, 2025Wells FargoOverweightOverweighthold

Financial Forecast


EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$7.70$6.35$1.82$5.98$4.80--
Avg Forecast$8.47$6.95$7.31$8.21$9.61$10.74$11.96
High Forecast$8.83$7.23$7.44$8.33$9.86$11.56$13.81
Low Forecast$8.14$6.70$7.11$8.02$9.36$8.49$8.58
Surprise %-9.09%-8.63%-75.10%-27.16%-50.05%--

Revenue Forecast

$60B $65B $70B $75B $80B $85B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$63.37B$67.97B$67.71B$69.94B$77.08B--
Avg Forecast$67.68B$77.30B$71.42B$72.81B$76.54B$79.69B$83.81B
High Forecast$69.88B$79.77B$72.37B$74.27B$79.27B$79.73B$83.81B
Low Forecast$65.63B$75.22B$70.70B$71.50B$74.72B$79.64B$83.81B
Surprise %-6.37%-12.08%-5.19%-3.95%0.71%--

Net Income Forecast

$1B $3B $5B $7B $9B $11B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$6.86B$5.28B$1.58B$4.43B$3.38B--
Avg Forecast$3.87B$2.40B$1.38B$6.23B$7.33B$7.64B$6.60B
High Forecast$4.64B$2.88B$1.66B$6.35B$7.52B$8.81B$10.52B
Low Forecast$3.10B$1.92B$1.10B$6.12B$7.14B$6.47B$6.54B
Surprise %77.11%120.52%14.35%-28.98%-53.89%--

MET Forecast FAQ


Is MetLife stock a buy?

MetLife stock has a consensus rating of Buy, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 24 Buy, 8 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MetLife is a favorable investment for most analysts.

What is MetLife's price target?

MetLife's price target, set by 32 Wall Street analysts, averages $95 over the next 12 months. The price target range spans from $84 at the low end to $101 at the high end, suggesting a potential 38.10% change from the previous closing price of $68.79.

How does MetLife stock forecast compare to its benchmarks?

MetLife's stock forecast shows a 38.10% upside, outperforming the average forecast for the financial services stocks sector (14.67%) and outperforming the life insurance stocks industry (23.69%).

What is the breakdown of analyst ratings for MetLife over the past three months?

  • March 2026: 17.65% Strong Buy, 47.06% Buy, 35.29% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 17.65% Strong Buy, 47.06% Buy, 35.29% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 17.65% Strong Buy, 52.94% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.

What is MetLife’s EPS forecast?

MetLife's average annual EPS forecast for its fiscal year ending in December 2026 is $10.74, marking a 123.75% increase from the reported $4.8 in 2025. Estimates for the following years are.

What is MetLife’s revenue forecast?

MetLife's average annual revenue forecast for its fiscal year ending in December 2026 is $79.69B, reflecting a 3.38% increase from the reported $77.08B in 2025. The forecast for.

What is MetLife’s net income forecast?

MetLife's net income forecast for the fiscal year ending in December 2026 stands at $7.64B, representing an 126.14% increase from the reported $3.38B in 2025. Projections indicate .